On June 26–28, 2026, Tbilisi is hosting the 8th Annual International Congress of Clinical Endocrinology. This large-scale forum, currently taking place at the Sheraton Grand Tbilisi Metechi Palace, brings together leading Georgian and international experts in a single space. Traditionally multidisciplinary in nature, the congress serves as an equally vital platform for endocrinologists, family physicians, internists, cardiologists, and gynecologists alike. The primary focus of the first, opening day of this three-day scientific event was placed on adrenal pathologies, lipid disorders, diabetes, and obesity.
Adrenal diseases emerged as the first central theme of the day among pathologies lying at the intersection of endocrinology and internal medicine. Scientific discussions were chiefly dedicated to adrenal masses (incidentalomas), primary aldosteronism, and pheochromocytoma. During the panel, experts emphasized the critical role of timely diagnosis and guideline-based management; these are disorders that are frequently discovered entirely by chance, yet can carry severe clinical consequences for the patient.
The program continued with a lipidology panel, further highlighting the close link between metabolic risk factors and cardiovascular diseases. During the session, Georgian and international colleagues actively discussed the modern management of dyslipidemia, alternatives to statins, and innovative combination therapies, while the progression of atherosclerosis itself was evaluated from a cardiological perspective. The review of rare lipid disorders added an even more specialized and profound dimension to the practical discussions, capturing significant interest from the audience.
The working program of the opening day concluded with a session on diabetes and obesity—a logical finale, given that these two nosologies represent the paramount challenges of modern endocrinological care. Speakers detailed the latest strategies in obesity management, inpatient hyperglycemia, and the cardiovascular safety profiles of antidiabetic medications. This panel served as a clear reflection of the growing trend in medicine shifting from the treatment of isolated nosologies toward patient-centered, multidisciplinary, and integrated care.
